E9-1156. National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. Start Printed Page 4046

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Mechanism of Immunological Tolerance.

    Date: February 19, 2009.

    Time: 10 a.m. to 1 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817.

    Contact Person: Cheryl K. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, DEA, NIAID/NIH/DHHS, 6700-B Rockledge Drive, MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598, clapham@niaid.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Start Signature

    Dated: January 13, 2009.

    Jennifer Spaeth,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. E9-1156 Filed 1-21-09; 8:45 am]

    BILLING CODE 4140-01-P